A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix--a Gynecologic Oncology Group Study.

Plaxe, S C; Blessing, J A; Lucci, J A; Hurteau, J A

Plaxe, S C; Blessing, J A; Lucci, J A; Hurteau, J A.

Affiliation

Plaxe SC; Gynecologic Oncology, University of California, San Diego, USA.

Invest New Drugs ; 19(1): 77-80, 2001.

Article in En | MEDLINE | ID: mdl-11291835

Subject(s)

Acridines/administration & dosage; Antineoplastic Agents/administration & dosage; Carcinoma, Squamous Cell/drug therapy; Pyrazoles/administration & dosage; Uterine Cervical Neoplasms/drug therapy; Acridines/adverse effects; Acridines/therapeutic use; Adult; Aged; Antineoplastic Agents/adverse effects; Antineoplastic Agents/therapeutic use; Carcinoma, Squamous Cell/pathology; Female; Humans; Middle Aged; Pyrazoles/adverse effects; Pyrazoles/therapeutic use; Treatment Outcome; Uterine Cervical Neoplasms/pathology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Acridines / Carcinoma, Squamous Cell / Uterine Cervical Neoplasms / Antineoplastic Agents Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Invest New Drugs Year: 2001 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links